Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 470 entries
Sorted by: Best Match Show Resources per page
Emerging therapies for the treatment of osteoporosis.

Journal of mid-life health

Bhutani G, Gupta MC.
PMID: 24672186
J Midlife Health. 2013 Jul;4(3):147-52. doi: 10.4103/0976-7800.118991.

Osteoporosis is a chronic disease of the osseous system characterized by decreased bone strength and increased fracture risk. It is due to an imbalance in the dynamic ongoing processes of bone formation and bone resorption. Currently available osteoporosis therapies...

Cite
Bhutani G, Gupta MC. Emerging therapies for the treatment of osteoporosis. J Midlife Health. 2013;4(3):147-52doi: 10.4103/0976-7800.118991.
Bhutani, G., & Gupta, M. C. (2013). Emerging therapies for the treatment of osteoporosis. Journal of mid-life health, 4(3), 147-52. https://doi.org/10.4103/0976-7800.118991
Bhutani, Garima, and Gupta, Mahesh Chander. "Emerging therapies for the treatment of osteoporosis." Journal of mid-life health vol. 4,3 (2013): 147-52. doi: https://doi.org/10.4103/0976-7800.118991
Bhutani G, Gupta MC. Emerging therapies for the treatment of osteoporosis. J Midlife Health. 2013 Jul;4(3):147-52. doi: 10.4103/0976-7800.118991. PMID: 24672186; PMCID: PMC3952405.
Copy Download .nbib Format: NLM
Successful treatment of osteonecrosis-induced fractured mandible with teriparatide therapy: A case report.

International journal of surgery case reports

Yao M, Shimo T, Ono Y, Obata K, Yoshioka N, Sasaki A.
PMID: 26947555
Int J Surg Case Rep. 2016;21:151-3. doi: 10.1016/j.ijscr.2016.02.028. Epub 2016 Mar 03.

INTRODUCTION: The management of medication-related osteonecrosis of the jaw (MRONJ) is controversial. To date, there is no established treatment for cases of advanced stage 3 MRONJ osteoporosis in elderly patients.PRESENTATION: An 87-year-old osteoporotic woman with osteonecrosis-induced left mandible fracture...

Cite
Yao M, Shimo T, Ono Y, et al. Successful treatment of osteonecrosis-induced fractured mandible with teriparatide therapy: A case report. Int J Surg Case Rep. 2016;21:151-3doi: 10.1016/j.ijscr.2016.02.028.
Yao, M., Shimo, T., Ono, Y., Obata, K., Yoshioka, N., & Sasaki, A. (2016). Successful treatment of osteonecrosis-induced fractured mandible with teriparatide therapy: A case report. International journal of surgery case reports, 21151-3. https://doi.org/10.1016/j.ijscr.2016.02.028
Yao, Mayumi, et al. "Successful treatment of osteonecrosis-induced fractured mandible with teriparatide therapy: A case report." International journal of surgery case reports vol. 21 (2016): 151-3. doi: https://doi.org/10.1016/j.ijscr.2016.02.028
Yao M, Shimo T, Ono Y, Obata K, Yoshioka N, Sasaki A. Successful treatment of osteonecrosis-induced fractured mandible with teriparatide therapy: A case report. Int J Surg Case Rep. 2016;21:151-3. doi: 10.1016/j.ijscr.2016.02.028. Epub 2016 Mar 03. PMID: 26947555; PMCID: PMC4834826.
Copy Download .nbib Format: NLM
Erratum to: Analysis of daily teriparatide treatment for osteoporosis in men.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

Niimi R, Kono T, Nishihara A, Hasegawa M, Matsumine A, Kono T, Sudo A.
PMID: 26092064
Osteoporos Int. 2015 Aug;26(8):2221. doi: 10.1007/s00198-015-3204-0.

No abstract available.

Cite
Niimi R, Kono T, Nishihara A, et al. Erratum to: Analysis of daily teriparatide treatment for osteoporosis in men. Osteoporos Int. 2015;26(8):2221doi: 10.1007/s00198-015-3204-0.
Niimi, R., Kono, T., Nishihara, A., Hasegawa, M., Matsumine, A., Kono, T., & Sudo, A. (2015). Erratum to: Analysis of daily teriparatide treatment for osteoporosis in men. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 26(8), 2221. https://doi.org/10.1007/s00198-015-3204-0
Niimi, R, et al. "Erratum to: Analysis of daily teriparatide treatment for osteoporosis in men." Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA vol. 26,8 (2015): 2221. doi: https://doi.org/10.1007/s00198-015-3204-0
Niimi R, Kono T, Nishihara A, Hasegawa M, Matsumine A, Kono T, Sudo A. Erratum to: Analysis of daily teriparatide treatment for osteoporosis in men. Osteoporos Int. 2015 Aug;26(8):2221. doi: 10.1007/s00198-015-3204-0. PMID: 26092064.
Copy Download .nbib Format: NLM
Preparation, statistical optimisation and in vitro characterisation of poly (3-hydroxybutyrate-co-3-hydroxyvalerate)/poly (lactic-co-glycolic acid) blend nanoparticles for prolonged delivery of teriparatide.

Journal of microencapsulation

Bahari Javan N, Rezaie Shirmard L, Jafary Omid N, Akbari Javar H, Rafiee Tehrani M, Abedin Dorkoosh F.
PMID: 27424890
J Microencapsul. 2016 Aug;33(5):460-474. doi: 10.1080/02652048.2016.1208296. Epub 2016 Jul 17.

The purpose of this study was the preparation, optimisation and in vitro characterisation of PHBV and PLGA blend nanoparticles (NPs) for prolonged delivery of Teriparatide. Double emulsion solvent evaporation technique was employed for the fabrication of NPs. The nanoformulation...

Cite
Bahari Javan N, Rezaie Shirmard L, Jafary Omid N, et al. Preparation, statistical optimisation and in vitro characterisation of poly (3-hydroxybutyrate-co-3-hydroxyvalerate)/poly (lactic-co-glycolic acid) blend nanoparticles for prolonged delivery of teriparatide. J Microencapsul. 2016;33(5):460-474doi: 10.1080/02652048.2016.1208296.
Bahari Javan, N., Rezaie Shirmard, L., Jafary Omid, N., Akbari Javar, H., Rafiee Tehrani, M., & Abedin Dorkoosh, F. (2016). Preparation, statistical optimisation and in vitro characterisation of poly (3-hydroxybutyrate-co-3-hydroxyvalerate)/poly (lactic-co-glycolic acid) blend nanoparticles for prolonged delivery of teriparatide. Journal of microencapsulation, 33(5), 460-474. https://doi.org/10.1080/02652048.2016.1208296
Bahari Javan, Nika, et al. "Preparation, statistical optimisation and in vitro characterisation of poly (3-hydroxybutyrate-co-3-hydroxyvalerate)/poly (lactic-co-glycolic acid) blend nanoparticles for prolonged delivery of teriparatide." Journal of microencapsulation vol. 33,5 (2016): 460-474. doi: https://doi.org/10.1080/02652048.2016.1208296
Bahari Javan N, Rezaie Shirmard L, Jafary Omid N, Akbari Javar H, Rafiee Tehrani M, Abedin Dorkoosh F. Preparation, statistical optimisation and in vitro characterisation of poly (3-hydroxybutyrate-co-3-hydroxyvalerate)/poly (lactic-co-glycolic acid) blend nanoparticles for prolonged delivery of teriparatide. J Microencapsul. 2016 Aug;33(5):460-474. doi: 10.1080/02652048.2016.1208296. Epub 2016 Jul 17. PMID: 27424890.
Copy Download .nbib Format: NLM
The influence of teriparatide in induced tooth movement: A systematic review.

Journal of clinical and experimental dentistry

Souza-Silva BN, Rodrigues JA, Moreira JC, Matos FS, Cesar CP, Repeke CE, Paranhos LR.
PMID: 27957280
J Clin Exp Dent. 2016 Dec 01;8(5):e615-e621. doi: 10.4317/jced.52997. eCollection 2016 Dec.

BACKGROUND: Teriparatide is a synthetic drug similar than PTH (parathyroid hormone), which is currently used as long-term treatment option for patients with bone chronic diseases, as osteoporosis; and this drug can interfere in a positive way in orthodontic movement....

Cite
Souza-Silva BN, Rodrigues JA, Moreira JC, et al. The influence of teriparatide in induced tooth movement: A systematic review. J Clin Exp Dent. 2016;8(5):e615-e621doi: 10.4317/jced.52997.
Souza-Silva, B. N., Rodrigues, J. A., Moreira, J. C., Matos, F. S., Cesar, C. P., Repeke, C. E., & Paranhos, L. R. (2016). The influence of teriparatide in induced tooth movement: A systematic review. Journal of clinical and experimental dentistry, 8(5), e615-e621. https://doi.org/10.4317/jced.52997
Souza-Silva, Bianca-Núbia, et al. "The influence of teriparatide in induced tooth movement: A systematic review." Journal of clinical and experimental dentistry vol. 8,5 (2016): e615-e621. doi: https://doi.org/10.4317/jced.52997
Souza-Silva BN, Rodrigues JA, Moreira JC, Matos FS, Cesar CP, Repeke CE, Paranhos LR. The influence of teriparatide in induced tooth movement: A systematic review. J Clin Exp Dent. 2016 Dec 01;8(5):e615-e621. doi: 10.4317/jced.52997. eCollection 2016 Dec. PMID: 27957280; PMCID: PMC5149101.
Copy Download .nbib Format: NLM
Screening, diagnosis and treatment of osteoporosis: a brief review.

Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases

Bernabei R, Martone AM, Ortolani E, Landi F, Marzetti E.
PMID: 25568654
Clin Cases Miner Bone Metab. 2014 Sep;11(3):201-7.

Osteoporosis is a highly prevalent condition characterized by decreases in bone mass and microarchitectural alterations. Bone fractures, especially of the hip and vertebrae, are the most burdensome complications of osteoporosis, being associated with high risk of disability, institutionalization and...

Cite
Bernabei R, Martone AM, Ortolani E, et al. Screening, diagnosis and treatment of osteoporosis: a brief review. Clin Cases Miner Bone Metab. 2014;11(3):201-7
Bernabei, R., Martone, A. M., Ortolani, E., Landi, F., & Marzetti, E. (2014). Screening, diagnosis and treatment of osteoporosis: a brief review. Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases, 11(3), 201-7.
Bernabei, Roberto, et al. "Screening, diagnosis and treatment of osteoporosis: a brief review." Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases vol. 11,3 (2014): 201-7.
Bernabei R, Martone AM, Ortolani E, Landi F, Marzetti E. Screening, diagnosis and treatment of osteoporosis: a brief review. Clin Cases Miner Bone Metab. 2014 Sep;11(3):201-7. PMID: 25568654; PMCID: PMC4269144.
Copy Download .nbib Format: NLM
Atypical femoral fracture in an osteogenesis imperfecta patient successfully treated with teriparatide.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists

Holm J, Eiken P, Hyldstrup L, Jensen JE.
PMID: 24936568
Endocr Pract. 2014 Oct;20(10):e187-90. doi: 10.4158/EP14141.CR.

OBJECTIVE: We report a case of a successfully healed atypical femoral fracture (AFF) following treatment with teriparatide in a patient with osteogenesis imperfecta (OI). To our knowledge, no successful treatment of AFFs with teriparatide in this subpopulation has ever...

Cite
Holm J, Eiken P, Hyldstrup L, et al. Atypical femoral fracture in an osteogenesis imperfecta patient successfully treated with teriparatide. Endocr Pract. 2014;20(10):e187-90doi: 10.4158/EP14141.CR.
Holm, J., Eiken, P., Hyldstrup, L., & Jensen, J. E. (2014). Atypical femoral fracture in an osteogenesis imperfecta patient successfully treated with teriparatide. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 20(10), e187-90. https://doi.org/10.4158/EP14141.CR
Holm, Jakob, et al. "Atypical femoral fracture in an osteogenesis imperfecta patient successfully treated with teriparatide." Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists vol. 20,10 (2014): e187-90. doi: https://doi.org/10.4158/EP14141.CR
Holm J, Eiken P, Hyldstrup L, Jensen JE. Atypical femoral fracture in an osteogenesis imperfecta patient successfully treated with teriparatide. Endocr Pract. 2014 Oct;20(10):e187-90. doi: 10.4158/EP14141.CR. PMID: 24936568.
Copy Download .nbib Format: NLM
Postmenopausal osteoporosis.

Nature reviews. Disease primers

Eastell R, O'Neill TW, Hofbauer LC, Langdahl B, Reid IR, Gold DT, Cummings SR.
PMID: 27681935
Nat Rev Dis Primers. 2016 Sep 29;2:16069. doi: 10.1038/nrdp.2016.69.

Osteoporosis is a metabolic bone disorder that is characterized by low bone mass and micro-architectural deterioration of bone tissue. Fractures of the proximal femur, the vertebrae and the distal radius are the most frequent osteoporotic fractures, although most fractures...

Cite
Eastell R, O'Neill TW, Hofbauer LC, et al. Postmenopausal osteoporosis. Nat Rev Dis Primers. 2016;2:16069doi: 10.1038/nrdp.2016.69.
Eastell, R., O'Neill, T. W., Hofbauer, L. C., Langdahl, B., Reid, I. R., Gold, D. T., & Cummings, S. R. (2016). Postmenopausal osteoporosis. Nature reviews. Disease primers, 216069. https://doi.org/10.1038/nrdp.2016.69
Eastell, Richard, et al. "Postmenopausal osteoporosis." Nature reviews. Disease primers vol. 2 (2016): 16069. doi: https://doi.org/10.1038/nrdp.2016.69
Eastell R, O'Neill TW, Hofbauer LC, Langdahl B, Reid IR, Gold DT, Cummings SR. Postmenopausal osteoporosis. Nat Rev Dis Primers. 2016 Sep 29;2:16069. doi: 10.1038/nrdp.2016.69. PMID: 27681935.
Copy Download .nbib Format: NLM
Gateways to clinical trials.

Methods and findings in experimental and clinical pharmacology

Bayes M, Rabasseda X, Prous JR.
PMID: 16845450
Methods Find Exp Clin Pharmacol. 2006 Jun;28(5):323-43.

Gateways to Clinical Trials are a guide to the most recent clinical trials in current literature and congresses. The data in the following tables have been retrieved from the Clinical Trials Knowledge Area of Prous Science Integrity, the drug...

Cite
Bayes M, Rabasseda X, Prous JR. Gateways to clinical trials. Methods Find Exp Clin Pharmacol. 2006;28(5):323-43
Bayes, M., Rabasseda, X., & Prous, J. R. (2006). Gateways to clinical trials. Methods and findings in experimental and clinical pharmacology, 28(5), 323-43.
Bayes, M, et al. "Gateways to clinical trials." Methods and findings in experimental and clinical pharmacology vol. 28,5 (2006): 323-43.
Bayes M, Rabasseda X, Prous JR. Gateways to clinical trials. Methods Find Exp Clin Pharmacol. 2006 Jun;28(5):323-43. PMID: 16845450.
Copy Download .nbib Format: NLM
Gateways to clinical trials.

Methods and findings in experimental and clinical pharmacology

Tomillero A, Moral MA.
PMID: 19557204
Methods Find Exp Clin Pharmacol. 2009 May;31(4):263-98. doi: 10.1358/mf.2009.31.4.1373959.

(-)-Gossypol; Abacavir sulfate/lamivudine, ACAM-1000, ACE-011, Agomelatine, AGS-004, Alemtuzumab, Alvocidib hydrochloride, AMG-317, Amlodipine, Aripiprazole, Atazanavir sulfate, Azacitidine; Becatecarin, Belinostat, Bevacizumab, BMS-387032, BMS-690514, Bortezomib; Casopitant mesylate, Cetuximab, Choline fenofibrate, CK-1827452, Clofarabine, Conivaptan hydrochloride; Dabigatran etexilate, DADMe-Immucillin-H, Darbepoetin alfa, Darunavir, Dasatinib, DC-WT1,...

Cite
Tomillero A, Moral MA. Gateways to clinical trials. Methods Find Exp Clin Pharmacol. 2009;31(4):263-98doi: 10.1358/mf.2009.31.4.1373959.
Tomillero, A., & Moral, M. A. (2009). Gateways to clinical trials. Methods and findings in experimental and clinical pharmacology, 31(4), 263-98. https://doi.org/10.1358/mf.2009.31.4.1373959
Tomillero, A, and Moral, M A. "Gateways to clinical trials." Methods and findings in experimental and clinical pharmacology vol. 31,4 (2009): 263-98. doi: https://doi.org/10.1358/mf.2009.31.4.1373959
Tomillero A, Moral MA. Gateways to clinical trials. Methods Find Exp Clin Pharmacol. 2009 May;31(4):263-98. doi: 10.1358/mf.2009.31.4.1373959. PMID: 19557204.
Copy Download .nbib Format: NLM
Osteoporosis and skeletal fractures.

HSS journal : the musculoskeletal journal of Hospital for Special Surgery

Gardner MJ, Demetrakopoulos D, Shindle MK, Griffith MH, Lane JM.
PMID: 18751849
HSS J. 2006 Feb;2(1):62-9. doi: 10.1007/s11420-005-0137-8.

Osteoporosis affects millions of individuals worldwide, rendering them susceptible to fragility fractures of the spine, hip, and wrist and leading to significant morbidity, mortality, and economic cost. Given the substantial impact of osteoporosis on both patients and the medical...

Cite
Gardner MJ, Demetrakopoulos D, Shindle MK, et al. Osteoporosis and skeletal fractures. HSS J. 2006;2(1):62-9doi: 10.1007/s11420-005-0137-8.
Gardner, M. J., Demetrakopoulos, D., Shindle, M. K., Griffith, M. H., & Lane, J. M. (2006). Osteoporosis and skeletal fractures. HSS journal : the musculoskeletal journal of Hospital for Special Surgery, 2(1), 62-9. https://doi.org/10.1007/s11420-005-0137-8
Gardner, Michael J, et al. "Osteoporosis and skeletal fractures." HSS journal : the musculoskeletal journal of Hospital for Special Surgery vol. 2,1 (2006): 62-9. doi: https://doi.org/10.1007/s11420-005-0137-8
Gardner MJ, Demetrakopoulos D, Shindle MK, Griffith MH, Lane JM. Osteoporosis and skeletal fractures. HSS J. 2006 Feb;2(1):62-9. doi: 10.1007/s11420-005-0137-8. PMID: 18751849; PMCID: PMC2504115.
Copy Download .nbib Format: NLM
Gateways to clinical trials.

Methods and findings in experimental and clinical pharmacology

Tomillero A, Moral MA.
PMID: 20508873
Methods Find Exp Clin Pharmacol. 2010 May;32(4):247-88. doi: 10.1358/mf.2010.32.4.1507200.

O(6)-Benzylguanine; (-)-Gossypol; Abatacept, AC-2592, Adalimumab, AIDSVAX gp120 B/E, Alemtuzumab, Aliskiren fumarate, ALVAC E120TMG, Ambrisentan, Amlodipine, Anakinra, Aripiprazole, Armodafinil, Atomoxetine hydrochloride, Avotermin; Bevacizumab, BIBW-2992, Bortezomib, Bosentan, Botulinum toxin type B; Canakinumab, CAT-354, Ciclesonide, CMV gB vaccine, Corifollitropin alfa, Daptomycin, Darbepoetin...

Cite
Tomillero A, Moral MA. Gateways to clinical trials. Methods Find Exp Clin Pharmacol. 2010;32(4):247-88doi: 10.1358/mf.2010.32.4.1507200.
Tomillero, A., & Moral, M. A. (2010). Gateways to clinical trials. Methods and findings in experimental and clinical pharmacology, 32(4), 247-88. https://doi.org/10.1358/mf.2010.32.4.1507200
Tomillero, A, and Moral, M A. "Gateways to clinical trials." Methods and findings in experimental and clinical pharmacology vol. 32,4 (2010): 247-88. doi: https://doi.org/10.1358/mf.2010.32.4.1507200
Tomillero A, Moral MA. Gateways to clinical trials. Methods Find Exp Clin Pharmacol. 2010 May;32(4):247-88. doi: 10.1358/mf.2010.32.4.1507200. PMID: 20508873.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 470 entries